1. Preclinical and clinical studies with selective reversible direct P2Y12 antagonists;van Giezen;Semin Thromb Haemost,2005
2. From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis;Springthorpe;Bioorg Med Chem Lett,2007
3. Direct oral P2Y12 receptor antagonist AZD6140 potently and reversibly binds to the rh-P2Y12 receptor expressed on CHO-K1 cells;van Giezen;Arterioscler Thromb Vasc Biol,2008
4. Single dose pharmacokinetics and pharmacodynamics of AZD6140;Peters;Haematologica,2004
5. Multiple-dose pharmacokinetics (PK) and pharmacodynamics (PD) of the oral reversible, orally active ADP receptor antagonist AZD6140;Peters;Eur Heart J,2006